IL-6 Trans-Signaling via the Soluble IL-6 Receptor: Importance for the Pro-Inflammatory Activities of IL-6

被引:773
作者
Rose-John, Stefan [1 ]
机构
[1] Univ Kiel, Dept Biochem, Inst Biochem, D-24098 Kiel, Germany
关键词
IL-6; receptor; shedding; soluble receptor; inflammation; inflammation associated cancer; HUMAN INTERLEUKIN-6 RECEPTOR; MULTICENTRIC CASTLEMAN-DISEASE; CYTOKINE-INDEPENDENT GROWTH; CORONARY-HEART-DISEASE; EMBRYONIC STEM-CELLS; REGULATORY T-CELLS; NORMAL HUMAN-URINE; VIRAL IL-6; IN-VIVO; STAT3; ACTIVATION;
D O I
10.7150/ijbs.4989
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Interleukin-6 (IL-6) is a cytokine with many activities. It has functions in the regulation of the immune system and the nervous system. Furthermore, IL-6 is involved in liver regeneration and in the metabolic control of the body. On target cells, IL-6 binds to an 80 kDa IL-6 receptor (IL-6R). The complex of IL-6 and IL-6R associates with a second protein, gp130, which thereupon dimerizes and initiates intracellular signaling. Whereas gp130 is expressed on all cells, IL-6R is only present on few cells in the body including hepatocytes and some leukocytes. Cells, which do not express IL-6R cannot respond to the cytokine, since gp130 alone has no measurable affinity for IL-6. Interestingly, a soluble form of IL-6R (sIL-6R) comprising the extracellular portion of the receptor can bind IL-6 with a similar affinity as the membrane bound IL-6R. The complex of IL-6 and sIL-6R can bind to gp130 on cells, which do not express the IL-6R, and which are unresponsive to IL-6. This process has been called trans-signaling. Here I will review published evidence that IL-6 trans-signaling is pro-inflammatory whereas classic IL-6 signaling via the membrane bound IL-6R is needed for regenerative or anti-inflammatory activities of the cytokine. Furthermore, the detailed knowledge of IL-6 biology has important consequences for therapeutic strategies aimed at the blockade of the cytokine IL-6.
引用
收藏
页码:1237 / 1247
页数:11
相关论文
共 106 条
[1]   Unraveling Viral Interleukin-6 Binding to gp130 and Activation of STAT-Signaling Pathways Independently of the Interleukin-6 Receptor [J].
Adam, Nina ;
Rabe, Bjoern ;
Suthaus, Jan ;
Groetzinger, Joachim ;
Rose-John, Stefan ;
Scheller, Juergen .
JOURNAL OF VIROLOGY, 2009, 83 (10) :5117-5126
[2]   Blockade of interleukin 6 trans signaling suppresses T-cell resistance against apoptosis in chronic intestinal inflammation:: Evidence in Crohn disease and experimental colitis in vivo [J].
Atreya, R ;
Mudter, J ;
Finotto, S ;
Müllberg, J ;
Jostock, T ;
Wirtz, S ;
Schütz, M ;
Bartsch, B ;
Holtmann, M ;
Becker, C ;
Strand, D ;
Czaja, J ;
Schlaak, JF ;
Lehr, HA ;
Autschbach, F ;
Schürmann, G ;
Nishimoto, N ;
Yoshizaki, K ;
Ito, H ;
Kishimoto, T ;
Galle, PR ;
Rose-John, S ;
Neurath, MF .
NATURE MEDICINE, 2000, 6 (05) :583-588
[3]   Distinct role of gp130 activation in promoting self-renewal divisions by mitogenically stimulated murine hematopoietic stem cells [J].
Audet, J ;
Miller, CL ;
Rose-John, S ;
Piret, JM ;
Eaves, CJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (04) :1757-1762
[4]   Selective blockade of interleukin-6 trans-signaling improves survival in a murine polymicrobial sepsis model [J].
Barkhausen, Tanja ;
Tschernig, Thomas ;
Rosenstiel, Philip ;
van Griensven, Martijn ;
Vonberg, Ralf-Peter ;
Dorsch, Martina ;
Mueller-Heine, Annika ;
Chalaris, Athena ;
Scheller, Juergen ;
Rose-John, Stefan ;
Seegert, Dirk ;
Krettek, Christian ;
Waetzig, Georg H. .
CRITICAL CARE MEDICINE, 2011, 39 (06) :1407-1413
[5]   HEMATOPOIETIC RECEPTORS AND HELICAL CYTOKINES [J].
BAZAN, JF .
IMMUNOLOGY TODAY, 1990, 11 (10) :350-354
[6]   TGF-β suppresses tumor progression in colon cancer by inhibition of IL-6 trans-signaling [J].
Becker, C ;
Fantini, MC ;
Schramm, C ;
Lehr, HA ;
Wirtz, S ;
Nikolaev, A ;
Burg, J ;
Strand, S ;
Kiesslich, R ;
Huber, S ;
Ito, H ;
Nishimoto, N ;
Yoshizaki, K ;
Nishimoto, N ;
Galle, PR ;
Blessing, M ;
Rose-John, S ;
Neurath, MF .
IMMUNITY, 2004, 21 (04) :491-501
[7]   Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells [J].
Bettelli, E ;
Carrier, YJ ;
Gao, WD ;
Korn, T ;
Strom, TB ;
Oukka, M ;
Weiner, HL ;
Kuchroo, VK .
NATURE, 2006, 441 (7090) :235-238
[8]   The interleukin-6 pathway and atherosclerosis [J].
Boekholdt, S. Matthijs ;
Stroes, Erik S. G. .
LANCET, 2012, 379 (9822) :1176-1178
[9]   gp130-Mediated Stat3 Activation in Enterocytes Regulates Cell Survival and Cell-Cycle Progression during Colitis-Associated Tumorigenesis [J].
Bollrath, Julia ;
Phesse, Toby J. ;
von Burstin, Vivian A. ;
Putoczki, Tracy ;
Bennecke, Moritz ;
Bateman, Trudie ;
Nebelsiek, Tim ;
Lundgren-May, Therese ;
Canli, Oezge ;
Schwitalla, Sarah ;
Matthews, Vance ;
Schmid, Roland M. ;
Kirchner, Thomas ;
Arkan, Melek C. ;
Ernst, Matthias ;
Greten, Florian R. .
CANCER CELL, 2009, 15 (02) :91-102
[10]   Cutting edge: Soluble IL-6R is produced by IL-6R ectodomain shedding in activated CD4 T cells [J].
Briso, Eva M. ;
Dienz, Oliver ;
Rincon, Mercedes .
JOURNAL OF IMMUNOLOGY, 2008, 180 (11) :7102-7106